Crossmark

Do successive intra-articular injections of tenoxicam or meloxicam affect the treatment outcomes of temporomandibular joint anterior disc displacement with reduction? (a randomized controlled trial)

Crossref DOI link: https://doi.org/10.1007/s10006-026-01552-6

Published Online: 2026-04-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gibaly, Amr https://orcid.org/0000-0003-3126-6816
Alghandour, Ahmed Nagi

Abdelmoiz, Mohamed
License Information

Text and Data Mining valid from 2026-04-10

Version of Record valid from 2026-04-10
More Information

Article History

Received: 30 September 2025

Accepted: 16 March 2026

First Online: 10 April 2026

Declarations

:

: The study was approved by the research ethics committee of the Faculty of Dental Medicine, Beni-Suef University (Approval #: REC-FDBSU/060062024–01/GA). All recruited patients signed informed consent after being told about the prospective intervention and the purpose and nature of the clinical trial.

: The study was registered on (#: NCT06403046) by Ahmed Nagi Alghandour on May 7, 2024.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below